Development of a copper-clioquinol formulation suitable for intravenous use

Clioquinol (CQ) is an FDA-approved topical antifungal agent known to kill cancer cells. This facilitated the initiation of clinical trials in patients with refractory hematologic malignancies. These repurposing efforts were not successful; this was likely due to low intracellular levels of the drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehbe, Moe, Malhotra, Armaan K., Anantha, Malathi, Lo, Cody, Dragowska, Wieslawa H., Dos Santos, Nancy, Bally, Marcel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756275/
https://www.ncbi.nlm.nih.gov/pubmed/29247315
http://dx.doi.org/10.1007/s13346-017-0455-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756275/
https://www.ncbi.nlm.nih.gov/pubmed/29247315
http://dx.doi.org/10.1007/s13346-017-0455-7

Ejemplares similares